2024 Britain's competition watchdog fined U.S. firm Viatris 1.5 million pounds ($1.88 million) on Friday for violating an order during its probe into pharma company Theramex's acquisition of ...

I rated Viatris a "Buy" last October, based on management's completion of "Phase 1" of its business transformation, and initiation of "Phase 2" of their strategic plan — returning to growth.

This leaflet answers some common questions about ENTECAVIR VIATRIS. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist.